Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 61681 - 61700 out of 561223 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Bahrain | (L01FF01) nivolumab | OPDIVO | 4ML, 10 MG/ML, CONCENTRATE FOR SOLUTION FOR INFUSION, 10MG/ML , 4ML | Retail price with vat |
$0-0 |
$0-0 |
Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Mesothelioma; Colorectal Neoplasms | BRISTOL-MYERSSQUIBBCOMPANY,USA. / WAELPHARMACY |
| Bahrain | (L01FF01) nivolumab | OPDIVO | 10ML, 10 MG/ML, CONCENTRATE FOR SOLUTION FOR INFUSION, 10MG/ML , 10ML | Retail price with vat |
$0-0 |
$0-0 |
Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Mesothelioma; Colorectal Neoplasms | BRISTOL-MYERSSQUIBBCOMPANY,USA. / WAELPHARMACY |
| Bahrain | (L01FF03) durvalumab | IMFINZI | 2.4ML, 120 MG/2.4ML, SOLUTION FOR INJECTION, 120MG/2.4ML , 2.4ML | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAUKLIMITED(CAMBRIDGE),UK. / WAELPHARMACY |
| Bahrain | (L01FF03) durvalumab | IMFINZI | 10ML, 500 MG/10ML, SOLUTION FOR INJECTION, 500MG/10ML , 10ML | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAUKLIMITED(CAMBRIDGE),UK. / WAELPHARMACY |
| Bahrain | (L01FF05) atezolizumab | TECENTRIQ | 20ML, 1200 MG, CONCENTRATE FOR SOLUTION FOR INFUSION, 1200MG , 20ML | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | F.HOFFMANNLAROCHELTD,SWITZERLAND. / YOUSUFMAHMOODHUSAINPHARMACYCO. |
| Bahrain | (L01FF05) atezolizumab | TECENTRIQ | 14ML, 840 MG, CONCENTRATE FOR SOLUTION FOR INFUSION, 840MG , 14ML | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | F.HOFFMANNLAROCHELTD,SWITZERLAND. / YOUSUFMAHMOODHUSAINPHARMACYCO. |
| Bahrain | (L01FG01) bevacizumab | AVASTIN | 4ML, 100 MG/4ML, CONCENTRATE FOR SOLUTION FOR INFUSION, 100MG/4ML , 4ML | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung; Breast Neoplasms; Ovarian Neoplasms; Colorectal Neoplasms; Carcinoma, Renal Cell | F.HOFFMANNLAROCHELTD,SWITZERLAND. / YOUSUFMAHMOODHUSAINPHARMACYCO. |
| Bahrain | (L01FG01) bevacizumab | AVASTIN | 16ML, 400 MG/16ML, CONCENTRATE FOR SOLUTION FOR INFUSION, 400MG/16ML , 16ML | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung; Breast Neoplasms; Ovarian Neoplasms; Colorectal Neoplasms; Carcinoma, Renal Cell | F.HOFFMANNLAROCHELTD,SWITZERLAND. / YOUSUFMAHMOODHUSAINPHARMACYCO. |
| Bahrain | (L01FG01) bevacizumab | KRABEVA | 4ML, 100 MG/4ML, CONCENTRATE FOR SOLUTION FOR INFUSION, 100MG/4ML , 4ML | Retail price with vat |
$0-0 |
$0-0 |
n/a | BIOCONBIOLOGICSUKLIMITED,UK / GULFPHARMACY |
| Bahrain | (L01FG01) bevacizumab | KRABEVA | 16ML, 400 MG/16ML, CONCENTRATE FOR SOLUTION FOR INFUSION, 400MG/16ML , 16ML | Retail price with vat |
$0-0 |
$0-0 |
n/a | BIOCONBIOLOGICSUKLIMITED,UK / GULFPHARMACY |
| Bahrain | (L01FG02) ramucirumab | CYRAMZA | 10ML, 100 MG/10ML, CONCENTRATE FOR SOLUTION FOR INFUSION, 100MG/10ML , 10ML | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms | ELILILLYANDCOMPANY,USA. / YOUSUFMAHMOODHUSAINPHARMACYCO. |
| Bahrain | (L01FG02) ramucirumab | CYRAMZA | 50ML, 500 MG/50ML, CONCENTRATE FOR SOLUTION FOR INFUSION, 500MG/50ML , 50ML | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms | ELILILLYANDCOMPANY,USA. / YOUSUFMAHMOODHUSAINPHARMACYCO. |
| Bahrain | (L01FX04) ipilimumab | YERVOY | 10ML, 50 MG/10ML, CONCENTRATE FOR SOLUTION FOR INFUSION, 50MG/10ML , 10ML | Retail price with vat |
$0-0 |
$0-0 |
Melanoma; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Mesothelioma, Malignant; Colorectal Neoplasms | BRISTOL-MYERSSQUIBBCOMPANY,USA. / WAELPHARMACY |
| Bahrain | (L01FX07) blinatumomab | BLINCYTO | 1, 35 MCG, POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION, 35MCG , 1 | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | AMGENINC,USA. / WAELPHARMACY |
| Bahrain | (L01FX12) tafasitamab | MINJUVI | 1, 200 MG, POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION, 200MG , 1 | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | INCYTEBIOSCIENCESINTERNATIONALSARL,SWITZERLAND. / WAELPHARMACY |
| Bahrain | (L01FX14) polatuzumab vedotin | POLIVY | 20ML, 140 MG, POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION, 140MG , 20ML | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, B-Cell | F.HOFFMANNLAROCHELTD,SWITZERLAND. / WAELPHARMACY |
| Bahrain | (L01FX14) polatuzumab vedotin | POLIVY | 6ML, 30 MG, POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION, 30MG , 6ML | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, B-Cell | F.HOFFMANNLAROCHELTD,SWITZERLAND. / WAELPHARMACY |
| Bahrain | (L01FX18) amivantamab | RYBREVANT | 1 X 7ML, 350 MG/7ML, CONCENTRATE FOR SOLUTION FOR INFUSION, 350MG/7ML , 1 X 7ML | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | JANSSENCILAGINTERNATIONALNV,BELGIUM. / WAELPHARMACY |
| Bahrain | (L01FX20) tremelimumab | IMJUDO | 1.25ML, 25 MG/1.25ML, CONCENTRATE FOR SOLUTION FOR INFUSION, 25MG/1.25ML , 1.25ML | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular | ASTRAZENECAAB,SWEDEN. / WAELPHARMACY |
| Bahrain | (L01FX20) tremelimumab | IMJUDO | 15ML, 300 MG/15ML, CONCENTRATE FOR SOLUTION FOR INFUSION, 300MG/15ML , 15ML | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular | ASTRAZENECAAB,SWEDEN. / WAELPHARMACY |
Pages
